Publications by authors named "Abey A"

Background: Hippocampal subfields perform specific roles in normal cognitive functioning and have distinct vulnerabilities in neurological disorders. However, measurement of subfields with MRI is technically difficult in the head and tail of the hippocampus. Recent studies have utilized curved multiplanar reconstruction (CMPR) to improve subfield visualization in the head and tail, but this method has not yet been applied to histological data.

View Article and Find Full Text PDF
Article Synopsis
  • Alzheimer's disease (AD) is a serious brain condition mostly found in older people, causing memory and thinking problems due to harmful proteins buildup in the brain.
  • Scientists studied how removing a protein called tau from human brain cells could help understand the effects of another harmful protein called amyloid-beta (Aβ) on brain functions.
  • The research showed that taking away tau reduced nerve cell activity and helped protect against damage from Aβ, suggesting that lowering tau levels could be a possible way to help treat AD in the future.
View Article and Find Full Text PDF

Background: Older companion dogs naturally develop a dementia-like syndrome with biological, clinical and therapeutic similarities to Alzheimer disease (AD). Given there has been no new safe, clinically effective and widely accessible treatment for AD for almost 20 years, an all-new cell therapeutic approach was trialled in canine veterinary patients, and further modelled in aged rats for more detailed neurobiological analysis.

Methods: A Phase 1/2A veterinary trial was conducted in N = 6 older companion dogs with definitive diagnosis of Canine Cognitive Dysfunction (CCD).

View Article and Find Full Text PDF

Some aged community dogs acquire a degenerative syndrome termed Canine Cognitive Dysfunction (CCD) that resembles human dementia because of Alzheimer's Disease (AD), with comparable cognitive and behavioral deficits. Dogs also have similar neuroanatomy, share our domestic environment and develop amyloid-β plaques, making them likely a valuable ecological model of AD. However, prior investigations have demonstrated a lack of neurofibrillary tau pathology in aged dogs, an important hallmark of AD, though elevated phosphorylated tau (p-tau) at the Serine 396 (S396) epitope has been reported in CCD.

View Article and Find Full Text PDF